|
Market Closed -
Nasdaq
04:00:00 24/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 56.73 USD | -2.44% |
|
-0.09% | +29.43% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14.06B | |||||
| 74.18B | |||||
| 59.55B | |||||
| 25.84B | - | ||||
| 24.73B | - | ||||
| 20.87B |
- Stock Market
- Stocks
- EXEL Stock
- Charts Exelixis, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
